BNTX BioNTech SE

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
EN
06/10/2020

Underlying

BNTXBioNTech SE

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BioNTech SE

 PRESS RELEASE
Free
BNTX BIONTECH SE

BioNTech auf dem ELCC-Kongress 2026: Neue klinische Daten unterstreich...

BioNTech auf dem ELCC-Kongress 2026: Neue klinische Daten unterstreichen das Potenzial des differenzierten, spätklinischen Portfolios bei Lungenkrebs Präsentationen zeigen Fortschritte in BioNTechs spätklinischen Programmen im Bereich Lungenkrebs und unterstreichen das Potenzial des differenzierten Unternehmensportfolios, welches Immunmodulatoren, Antikörper-Wirkstoff-Konjugate und mRNA-Krebsimmuntherapien sowie deren Kombinationen umfasstDaten-Updates zu Pumitamig aus drei klinischen Studien in China unterstreichen das bereits beobachtete Wirksamkeits- und Sicherheitsprofil des bispezifisc...

March 24, 2026 1 EN
 PRESS RELEASE
Free
BNTX BIONTECH SE

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentia...

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer Presentations showcase progress in BioNTech’s late-stage lung cancer programs, reinforcing the potential of the Company’s differentiated portfolio spanning immunomodulators, antibody-drug conjugates, mRNA cancer immunotherapies, and their combinationsData updates for pumitamig, a PD-L1xVEGF-A bispecific immunomodulator, from three clinical trials conducted in China further strengthen the evidence supporting its previously observed efficacy and safety profile in lung cancerResults of...

March 24, 2026 1 EN
Martial Descoutures
  • Martial Descoutures
DGE DIAGEO PLC
BKW BKW AG
RNO RENAULT SA
RI PERNOD RICARD SA
RCO REMY COINTREAU SA
LONN LONZA GROUP AG
RHM RHEINMETALL AG
RBI RAIFFEISEN BANK INTERNATIONAL AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
REP REPSOL SA
ASM ASM INTERNATIONAL N.V.
ITX INDUSTRIA DE DISENO TEXTIL S.A.
MERLIN MERLIN PROPERTIES SOCIMI S.A.
BNTX BIONTECH SE
CPR DAVIDE CAMPARI-MILANO N.V.
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
UN0 UNIPER SE
CVC CVC CAPITAL PARTNERS PLC
03/11/26 March 11, 2026 1 EN
Martial Descoutures
  • Martial Descoutures
DGE DIAGEO PLC
BKW BKW AG
RNO RENAULT SA
RI PERNOD RICARD SA
RCO REMY COINTREAU SA
LONN LONZA GROUP AG
RHM RHEINMETALL AG
RBI RAIFFEISEN BANK INTERNATIONAL AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
REP REPSOL SA
ASM ASM INTERNATIONAL N.V.
ITX INDUSTRIA DE DISENO TEXTIL S.A.
MERLIN MERLIN PROPERTIES SOCIMI S.A.
BNTX BIONTECH SE
CPR DAVIDE CAMPARI-MILANO N.V.
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
UN0 UNIPER SE
CVC CVC CAPITAL PARTNERS PLC
03/11/26 March 11, 2026 1 FR
Martial Descoutures
  • Martial Descoutures
03/11/26 March 11, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch